Nova Patents
AT531728T

Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth

Abstract

This record has no abstract on file.

Term

Term ended

Expired 14 August 2021, 5.1 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

45 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
63883400United States of AmericaA
0125502United States of AmericaW

Members45

Family members, oldest first
DocumentOfficeKind
CA2361181A1CanadaA1
WO0044403A1World Intellectual Property Organization (WIPO)A1
AU4795100AAustraliaA
CA2400473A1CanadaA1
WO0161356A1World Intellectual Property Organization (WIPO)A1
AU4157501AAustraliaA
EP1144004A1European Patent Office (EPO)A1
CA2419133A1CanadaA1
WO0214470A2World Intellectual Property Organization (WIPO)A2
AU2001286483A2AustraliaA2
AU8648301AAustraliaA
US6414130B1United States of AmericaB1
EP1144004A4European Patent Office (EPO)A4
JP2002534995AJapanA
WO0161356A9World Intellectual Property Organization (WIPO)A9
EP1257822A1European Patent Office (EPO)A1
WO0214470A3World Intellectual Property Organization (WIPO)A3
EP1311290A2European Patent Office (EPO)A2
JP2004501605AJapanA
US2004022785A1United States of AmericaA1
US2004052796A1United States of AmericaA1
EP1311290A4European Patent Office (EPO)A4
EP1257822A4European Patent Office (EPO)A4
JP2004529847AJapanA
AU777422B2AustraliaB2
AU2001286483B2AustraliaB2
US7393823B1United States of AmericaB1
US7396810B1United States of AmericaB1
US2008219997A1United States of AmericaA1
US7608269B2United States of AmericaB2
US2009270316A1United States of AmericaA1
US7625859B1United States of AmericaB1
US2010119521A1United States of AmericaA1
US2010267027A1United States of AmericaA1
CA2361181CCanadaC
US7935784B2United States of AmericaB2
US7939080B2United States of AmericaB2
EP1311290B1European Patent Office (EPO)B1
AT531728TThis recordAustriaT
ATE531728T1AustriaT1
EP1257822B1European Patent Office (EPO)B1
AT542138TAustriaT
ATE542138T1AustriaT1
US2012045755A1United States of AmericaA1
US2012088255A1United States of AmericaA1